E-LIB Suche - Ergebnisse für: Privolnev, Y

1

EE109 BoNT-As for Adult Upper Limb Spasticity: Cost of Trea..:

Privolnev, Y ; Johnston, K ; Griffin, E
Value in Health. 27 (2024) 6 - p. S77 , 2024

Link: https://doi.org/10.1016/..

2

HTA65 How Does Conditional Regulatory Approval Affect the R..:

Privolnev, Y ; Liovas, A ; Chan, L
Value in Health. 27 (2024) 6 - p. S256 , 2024

Link: https://doi.org/10.1016/..

3

HTA43 Do Complexities of Combination Oncology Submissions I..:

Liovas, A. ; Privolnev, Y. ; Pan, V..
Value in Health. 26 (2023) 6 - p. S266 , 2023

Link: https://doi.org/10.1016/..

4

EE46 BoNT-As for Cervical Dystonia: Cost of Treatment and R..:

Johnston, K. ; Griffin, E. ; Privolnev, Y.
Value in Health. 26 (2023) 12 - p. S58 , 2023

Link: https://doi.org/10.1016/..

5

HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiatio..:

Privolnev, Y ; Liovas, A ; Jakac-Sinclair, N
Value in Health. 25 (2022) 12 - p. S336 , 2022

Link: https://doi.org/10.1016/..

6

PDB80 DIABETIC MACULAR EDEMA IN EUROPE: THE IMPACT OF PAYER..:

Privolnev, Y. ; Cox, J. ; McFadden, E..
Value in Health. 22 (2019) - p. S587 , 2019

Link: https://doi.org/10.1016/..

7

PRO88 PAYER AND PHYSICIAN PERSPECTIVES OF CURRENT AND EMERG..:

Privolnev, Y. ; Duarte, H. ; Saini, A.
Value in Health. 22 (2019) - p. S857 , 2019

Link: https://doi.org/10.1016/..

8

PGI42 THE NEW WAVE OF ULCERATIVE COLITIS BIOLOGICS: CONSTRA..:

Privolnev, Y. ; Kravit, A. ; Duarte, H..
Value in Health. 22 (2019) - p. S623 , 2019

Link: https://doi.org/10.1016/..

9

PBI26 SINK OR SWIM: HOW CAN SLE BIOLOGICS SUCCESSFULLY ACHI..:

Privolnev, Y. ; Albacker, C. ; Nasa, M.
Value in Health. 22 (2019) - p. S51-S52 , 2019

Link: https://doi.org/10.1016/..

10

PBI47 PAYER AND PRESCRIBER PERSPECTIVES ON CHIMERIC ANTIGEN..:

Privolnev, Y. ; Vinuesa, L.
Value in Health. 22 (2019) - p. S425 , 2019

Link: https://doi.org/10.1016/..

11

PCN355 DO PAYER AND PRESCRIBER ENDPOINT PREFERENCES ALIGN?:..:

Privolnev, Y. ; Adler, B.
Value in Health. 22 (2019) - p. S505 , 2019

Link: https://doi.org/10.1016/..

12

PCN235 - COMBINATION ONCOLOGY THERAPIES IN THE EU5: NAVIGAT..:

Privolnev, Y. ; Cox, J. ; Webster, R.
Value in Health. 21 (2018) - p. S54 , 2018

Link: https://doi.org/10.1016/..

13

PSY157 - EMERGING RHEUMATOID ARTHRITIS AND PSORIASIS BIOLOG..:

Privolnev, Y. ; Cox, J. ; Reyes, A.
Value in Health. 21 (2018) - p. S463 , 2018

Link: https://doi.org/10.1016/..

14

PUK26 - IMPACT OF EMERGING HIF-PH INHIBITORS ON RENAL ANEMI..:

Khan, J. ; Blackstock, T. ; Privolnev, Y..
Value in Health. 21 (2018) - p. S479 , 2018

Link: https://doi.org/10.1016/..

15

PHP181 - HEALTH TECHNOLOGY ASSESSMENT OF ONCOLOGY THERAPIES..:

Privolnev, Y. ; Moore, R. ; Sharma, K.
Value in Health. 21 (2018) - p. S180 , 2018

Link: https://doi.org/10.1016/..